Concord Drugs Limited (CONCORD.BO)
INR 36.45
(-2.72%)
INR 36.45
(-2.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 40.52 Million INR | -12.25% |
| 2022 | 45.8 Million INR | -57.39% |
| 2021 | 56.78 Million INR | 230.13% |
| 2020 | 32.82 Million INR | -1.78% |
| 2019 | 34.32 Million INR | -10.5% |
| 2018 | 37.34 Million INR | -23.91% |
| 2017 | 49.08 Million INR | -13.16% |
| 2016 | 56.51 Million INR | -33.48% |
| 2015 | 84.96 Million INR | 14.91% |
| 2014 | 73.93 Million INR | 120.61% |
| 2013 | 33.51 Million INR | 44.81% |
| 2012 | 23.14 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 8.32 Million INR | 137.16% |
| 2023 FY | - INR | -12.25% |
| 2023 Q4 | 3.5 Million INR | -44.22% |
| 2023 Q3 | 6.29 Million INR | -60.99% |
| 2023 Q2 | 16.12 Million INR | 10.53% |
| 2023 Q1 | 14.59 Million INR | 47.18% |
| 2022 Q4 | 9.91 Million INR | -31.39% |
| 2022 FY | - INR | -57.39% |
| 2022 Q3 | 14.44 Million INR | 21.81% |
| 2022 Q2 | 11.86 Million INR | 20.99% |
| 2022 Q1 | 9.8 Million INR | -83.17% |
| 2021 Q1 | 22.89 Million INR | 263.42% |
| 2021 Q2 | 16.66 Million INR | -27.21% |
| 2021 Q4 | 58.25 Million INR | 451.44% |
| 2021 Q3 | 10.56 Million INR | -36.61% |
| 2021 FY | - INR | 230.13% |
| 2020 Q4 | 6.3 Million INR | -4.33% |
| 2020 FY | - INR | -1.78% |
| 2020 Q3 | 6.58 Million INR | -29.07% |
| 2020 Q1 | 9.79 Million INR | 31.21% |
| 2020 Q2 | 9.28 Million INR | -5.26% |
| 2019 FY | - INR | -10.5% |
| 2019 Q2 | 8.98 Million INR | -7.72% |
| 2019 Q4 | 7.46 Million INR | -10.4% |
| 2019 Q3 | 8.33 Million INR | -7.24% |
| 2019 Q1 | 9.73 Million INR | 38.13% |
| 2018 Q2 | 9.86 Million INR | -3.94% |
| 2018 FY | - INR | -23.91% |
| 2018 Q4 | 7.05 Million INR | -29.72% |
| 2018 Q1 | 10.27 Million INR | -17.07% |
| 2018 Q3 | 10.03 Million INR | 1.64% |
| 2017 Q1 | 11.81 Million INR | 265.76% |
| 2017 FY | - INR | -13.16% |
| 2017 Q4 | 12.38 Million INR | -19.52% |
| 2017 Q3 | 15.39 Million INR | 60.71% |
| 2017 Q2 | 9.57 Million INR | -18.93% |
| 2016 Q1 | 15.37 Million INR | -3.52% |
| 2016 FY | - INR | -33.48% |
| 2016 Q3 | 30.85 Million INR | 83.4% |
| 2016 Q4 | -7.12 Million INR | -123.1% |
| 2016 Q2 | 16.82 Million INR | 9.44% |
| 2015 Q4 | 15.93 Million INR | -62.09% |
| 2015 Q2 | 17.28 Million INR | 2.05% |
| 2015 Q1 | 16.93 Million INR | 442.67% |
| 2015 FY | - INR | 14.91% |
| 2015 Q3 | 42.02 Million INR | 143.11% |
| 2014 Q1 | 13.84 Million INR | 41.59% |
| 2014 FY | - INR | 120.61% |
| 2014 Q4 | 3.12 Million INR | -78.84% |
| 2014 Q3 | 14.75 Million INR | 5.46% |
| 2014 Q2 | 13.98 Million INR | 1.03% |
| 2013 Q3 | 7.58 Million INR | 7.57% |
| 2013 Q2 | 7.05 Million INR | 0.48% |
| 2013 Q4 | 9.77 Million INR | 28.85% |
| 2013 FY | - INR | 44.81% |
| 2013 Q1 | 7.02 Million INR | 58.65% |
| 2012 FY | - INR | 0.0% |
| 2012 Q4 | 4.42 Million INR | -28.74% |
| 2012 Q3 | 6.21 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -6243.6% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -249.793% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 54.477% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 51.891% |
| Sunil Healthcare Limited | 93.07 Million INR | 56.467% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -145.308% |
| MedPlus Health Services Limited | 3.94 Billion INR | 98.972% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 126.825% |
| Patidar Buildcon Limited | -5.52 Million INR | 833.261% |
| Roopa Industries Limited | 55.7 Million INR | 27.254% |
| Smruthi Organics Limited | 120.31 Million INR | 66.321% |
| Trident Lifeline Limited | 102.69 Million INR | 60.543% |
| PANJON LTD. | 4.08 Million INR | -890.951% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 132.868% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -155.212% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 312.681% |
| Anuh Pharma Limited | 878.5 Million INR | 95.388% |
| Crestchem Limited | 30.33 Million INR | -33.578% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 474.561% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -49.009% |
| Tyche Industries Limited | 128.2 Million INR | 68.395% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 89.583% |
| Trimurthi Limited | -2.47 Million INR | 1734.853% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 81.292% |
| Norris Medicines Limited | -1.78 Million INR | 2371.116% |
| Zenlabs Ethica Limited | 27.09 Million INR | -49.542% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 89.528% |
| ANG Lifesciences India Limited | 90.66 Million INR | 55.307% |
| Parmax Pharma Limited | 22.93 Million INR | -76.654% |
| Veerhealth Care Limited | 15.99 Million INR | -153.329% |
| Deccan Health Care Limited | 37.5 Million INR | -8.036% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 84.058% |
| Makers Laboratories Limited | 25.81 Million INR | -56.981% |
| Lactose (India) Limited | 201.22 Million INR | 79.863% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 142.133% |
| Zenith Healthcare Limited | 4.98 Million INR | -712.35% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 53.735% |
| Bacil Pharma Limited | -569.32 Thousand INR | 7217.263% |
| PRAVEG LIMITED | 321.43 Million INR | 87.394% |
| Denis Chem Lab Limited | 224.84 Million INR | 81.979% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 93.362% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 89.276% |
| Colinz Laboratories Limited | 5.42 Million INR | -646.5% |
| Godavari Drugs Limited | 134.62 Million INR | 69.902% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 10080.296% |
| Zenotech Laboratories Limited | 172.64 Million INR | 76.53% |
| Panchsheel Organics Limited | 189.36 Million INR | 78.602% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 90.971% |
| Vivanza Biosciences Limited | 11.2 Million INR | -261.657% |
| Phaarmasia Limited | -1.58 Million INR | 2661.315% |
| Sastasundar Ventures Limited | -203.51 Million INR | 119.91% |
| Medi-Caps Limited | 4.77 Million INR | -749.298% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 1589.706% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 95.124% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 76.245% |
| Mercury Laboratories Limited | 101.18 Million INR | 59.956% |
| Gennex Laboratories Limited | 219.35 Million INR | 81.528% |
| BDH Industries Limited | 124.27 Million INR | 67.394% |
| Coral Laboratories Limited | 227.07 Million INR | 82.156% |
| Bharat Parenterals Limited | 265.74 Million INR | 84.752% |
| Beryl Drugs Limited | 26.63 Million INR | -52.108% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 225.143% |
| Evoq Remedies Limited | 6.18 Million INR | -554.818% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 50.953% |
| Transchem Limited | 56.61 Million INR | 28.424% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -240.848% |
| Parnax Lab Limited | 243.59 Million INR | 83.366% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 9.562% |
| Kerala Ayurveda Limited | 70.78 Million INR | 42.758% |
| Cian Healthcare Limited | 122.56 Million INR | 66.941% |
| Trinity League India Limited | -26.25 Million INR | 254.344% |
| Syschem (India) Limited | 70.4 Million INR | 42.444% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 572.647% |
| Natural Capsules Limited | 219.9 Million INR | 81.573% |
| Auro Laboratories Limited | 121.73 Million INR | 66.715% |